Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0553-2022Class II

ARIES HSV 1&2 Assay, Catalog/REF# 50-10017

Luminex Corporation / initiated 2021-11-17 / Terminated / root cause: manufacturing process

Luminex Corporation began a recall of ARIES HSV 1&2 Assay, Catalog/REF# 50-10017 on . FDA classified it as Class II and gives the reason as "Impacted lot may leak inside the ARIES instrument. Testing confirmed a leak rate of 0.9%. Leaking cassettes could potentially lead to incorrect results or a delay in reporting results due to an Invalid". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-0553-2022
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Luminex Corporation
Product
ARIES HSV 1&2 Assay, Catalog/REF# 50-10017
Product code
OOI Real Time Nucleic Acid Amplification System
Reason for recall
Impacted lot may leak inside the ARIES instrument. Testing confirmed a leak rate of 0.9%. Leaking cassettes could potentially lead to incorrect results or a delay in reporting results due to an Invalid.
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
On 11/17/2021, the firm notified affected customers via letter titled, "URGENT: MEDICAL DEVICE RECALL ARIES HSV 1&2 Assay." The letter indicated, if you observe any leaks, please contact Luminex Global Support Services at [email protected]. Please inform all those who need to be aware within your organization of this potential product performance issue. Please contact Luminex Global Support Services at [email protected] at your earliest convenience if you have a Kit with an affected lot to arrange for its replacement, and to confirm the disposal of any remaining Kits in your inventory. We ask that you complete and return the attached acknowledgement letter so that we can confirm the destruction of recalled lots. Luminex Global Support Services, 1-877-785-2323 (U.S. and Canada}, +1-512-381-4397 (Outside U.S. and Canada), [email protected]
Quantity in commerce
329
Distribution
Worldwide distribution - US Nationwide distribution in the states of New Jersey, California, Connecticut, Minnesota, Missouri, New Jersey, New Mexico, Pennsylvania, Tennessee, Washington, and Wisconsin) and the country of Malaysia.
Product codes and lots
Lot Numbers AB3600A and AB3560A

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0553-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0553-2022Class IITerminatedVoluntary: Firm initiated